DBD

Diebold NixdorfNYSE:DBD Stock Report

Market Cap

US$773.4m

7D

-3.9%

1Y

38.2%

Updated

22 Sep, 2021

Data

Company Financials +
DBD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance0/6
Financial Health1/6
Dividends0/6

DBD Overview

Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico, and Latin America.

Diebold Nixdorf Competitors

Dell Technologies

NYSE:DELL

US$76.0b

HP

NYSE:HPQ

US$31.8b

Oracle

NYSE:ORCL

US$242.2b

Honeywell International

NasdaqGS:HON

US$149.8b

Price History & Performance

Summary of all time highs, changes and price drops for Diebold Nixdorf
Historical stock prices
Current Share PriceUS$9.87
52 Week HighUS$5.97
52 Week LowUS$17.30
Beta3.33
1 Month Change-6.62%
3 Month Change-27.05%
1 Year Change38.24%
3 Year Change116.92%
5 Year Change-60.38%
Change since IPO26.10%

Recent News & Updates

Jul 09

Diebold Nixdorf Secures Stability Through Various Deals Despite Financial Risks

Extended contracts in rolling out self-checkout products and the DN Series ATMs will drive DBD’s topline. Increased opportunities in managed services in the retail and banking segment can drive the business in the medium term. Its negative shareholders' equity poses financial risks; however, no near-term debt maturities and the expected improvement in cash flows mitigate some of the risk factors. The stock is relatively undervalued and provides investment opportunities at this level.

Shareholder Returns

DBDUS TechUS Market
7D-3.9%-2.7%-1.7%
1Y38.2%40.4%36.2%

Return vs Industry: DBD exceeded the US Tech industry which returned 33.1% over the past year.

Return vs Market: DBD exceeded the US Market which returned 31.5% over the past year.

Price Volatility

Is DBD's price volatile compared to industry and market?
DBD volatility
DBD Beta3.33
Industry Beta1.2
Market Beta1

Stable Share Price: DBD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: DBD's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
185922,000Gerrard Schmidhttps://www.dieboldnixdorf.com

Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico, and Latin America. The company operates through Eurasia Banking, Americas Banking, and Retail segments. It offers cash recyclers and dispensers, intelligent deposit terminals, teller automation tools, and kiosk technologies, as well as physical security solutions; and front-end applications for consumer connection points and back-end platforms that manage channel transactions, operations and integration and facilitate omnichannel transactions, endpoint monitoring, remote asset management, customer marketing, merchandise management, and analytics.

Diebold Nixdorf Fundamentals Summary

How do Diebold Nixdorf's earnings and revenue compare to its market cap?
DBD fundamental statistics
Market CapUS$773.35m
Earnings (TTM)-US$191.00m
Revenue (TTM)US$3.99b

0.2x

P/S Ratio

-4.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DBD income statement (TTM)
RevenueUS$3.99b
Cost of RevenueUS$2.86b
Gross ProfitUS$1.13b
ExpensesUS$1.32b
Earnings-US$191.00m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Oct 25, 2021

Earnings per share (EPS)-2.45
Gross Margin28.23%
Net Profit Margin-4.79%
Debt/Equity Ratio-279.2%

How did DBD perform over the long term?

See historical performance and comparison

Valuation

Is Diebold Nixdorf undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: DBD ($9.87) is trading below our estimate of fair value ($28.42)

Significantly Below Fair Value: DBD is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: DBD is unprofitable, so we can't compare its PE Ratio to the US Tech industry average.

PE vs Market: DBD is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate DBD's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: DBD has negative assets, so we can't compare its PB Ratio to the US Tech industry average.


Future Growth

How is Diebold Nixdorf forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

89.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: DBD is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: DBD is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: DBD's is expected to become profitable in the next 3 years.

Revenue vs Market: DBD's revenue (3.3% per year) is forecast to grow slower than the US market (9.8% per year).

High Growth Revenue: DBD's revenue (3.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if DBD's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Diebold Nixdorf performed over the past 5 years?

-10.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: DBD is currently unprofitable.

Growing Profit Margin: DBD is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: DBD is unprofitable, and losses have increased over the past 5 years at a rate of 10.6% per year.

Accelerating Growth: Unable to compare DBD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DBD is unprofitable, making it difficult to compare its past year earnings growth to the Tech industry (48.6%).


Return on Equity

High ROE: DBD's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Financial Health

How is Diebold Nixdorf's financial position?


Financial Position Analysis

Short Term Liabilities: DBD has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: DBD has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: DBD has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: DBD's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: DBD has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if DBD has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Diebold Nixdorf current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate DBD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate DBD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if DBD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if DBD's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: DBD is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of DBD's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.6yrs

Average management tenure


CEO

Gerrard Schmid (52 yo)

3.58yrs

Tenure

US$5,312,150

Compensation

Mr. Gerrard B. Schmid serves as Director of Array Technologies, Inc. since August 2, 2021. He has been President and Chief executive Officer of Diebold Nixdorf, Incorporated since February 2018 and has bee...


CEO Compensation Analysis

Compensation vs Market: Gerrard's total compensation ($USD5.31M) is above average for companies of similar size in the US market ($USD2.39M).

Compensation vs Earnings: Gerrard's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: DBD's management team is considered experienced (3.6 years average tenure).


Board Members

Experienced Board: DBD's board of directors are considered experienced (3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: DBD insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Diebold Nixdorf, Incorporated's employee growth, exchange listings and data sources


Key Information

  • Name: Diebold Nixdorf, Incorporated
  • Ticker: DBD
  • Exchange: NYSE
  • Founded: 1859
  • Industry: Technology Hardware, Storage and Peripherals
  • Sector: Tech
  • Market Cap: US$773.352m
  • Shares outstanding: 78.35m
  • Website: https://www.dieboldnixdorf.com

Number of Employees


Location

  • Diebold Nixdorf, Incorporated
  • 5995 Mayfair Road
  • PO Box 3077
  • North Canton
  • Ohio
  • 44720-8077
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/22 22:32
End of Day Share Price2021/09/22 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.